REtreatment With VEnetoclax and Acalabrutinib After Venetoclax Limited Duration (REVEAL)
REtreatment With VEnetoclax and Acalabrutinib After Venetoclax Limited Duration (REVEAL)
Recruiting · NCT04523428 · Registry updated 2026-09-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| REtreatment With VEnetoclax and Acalabrutinib After Venetoclax Limited Duration (REVEAL) | chronic lymphocytic leukemia/small lymphocytic lymphoma | Recruiting | Phase 2 | 2026-09-21 | NCT04523428 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Stichting Hemato-Oncologie voor Volwassenen Nederland | 27 |
18 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| BE-Bruxelles-STLUC | Brussels | Belgium | 7 |
| BE-Leuven-UZLEUVEN | Leuven | Belgium | 10 |
| DK-Aarhus N-AUH | Aarhus | Denmark | 2 |
| NL-Amsterdam-AMC | Amsterdam | Netherlands | 10 |
| NL-Arnhem-RIJNSTATE | Arnhem | Netherlands | 11 |
| NL-Breda-AMPHIA | Breda | Netherlands | 10 |
| NL-Delft-RDGG | Delft | Netherlands | 8 |
| NL-Den Bosch-JBZ | 's-Hertogenbosch | Netherlands | 14 |
| NL-Dordrecht-ASZ | Dordrecht | Netherlands | 14 |
| NL-Ede-ZGV | Ede | Netherlands | 6 |
| NL-Eindhoven-MAXIMAMC | Eindhoven | Netherlands | 11 |
| NL-Groningen-UMCG | Groningen | Netherlands | 17 |
| NL-Leeuwarden-MCL | Leeuwarden | Netherlands | 10 |
| NL-Maastricht-MUMC | Maastricht | Netherlands | 13 |
| NL-Nieuwegein-ANTONIUS | Nieuwegein | Netherlands | 10 |
| NL-Rotterdam-IKAZIA | Rotterdam | Netherlands | 4 |
| NL-Rotterdam-MAASSTADZIEKENHUIS | Rotterdam | Netherlands | 3 |
| NL-Utrecht-UMCUTRECHT | Utrecht | Netherlands | 16 |